West Pharmaceutical Services (WST) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

West Pharmaceutical Services Revenue Highlights

Latest Revenue (Y)

$3.07B

Latest Revenue (Q)

$804.70M

Main Segment (Y)

Proprietary Products

Main Geography (Y)

UNITED STATES

West Pharmaceutical Services Revenue by Period

West Pharmaceutical Services Revenue by Year

Date	Revenue	Change
2025-12-31	$3.07B	6.26%
2024-12-31	$2.89B	-1.98%
2023-12-31	$2.95B	2.27%
2022-12-31	$2.89B	1.94%
2021-12-31	$2.83B	31.86%
2020-12-31	$2.15B	16.44%
2019-12-31	$1.84B	7.31%
2018-12-31	$1.72B	7.36%
2017-12-31	$1.60B	6.04%
2016-12-31	$1.51B	7.95%
2015-12-31	$1.40B	-1.67%
2014-12-31	$1.42B	3.91%
2013-12-31	$1.37B	8.04%
2012-12-31	$1.27B	6.19%
2011-12-31	$1.19B	7.96%
2010-12-31	$1.10B	4.64%
2009-12-31	$1.06B	0.44%
2008-12-31	$1.05B	3.04%
2007-12-31	$1.02B	11.69%
2006-12-31	$913.30M	30.53%
2005-12-31	$699.70M	29.19%
2004-12-31	$541.60M	10.37%
2003-12-31	$490.70M	16.92%
2002-12-31	$419.70M	5.74%
2001-12-31	$396.90M	-7.72%
2000-12-31	$430.10M	-8.31%
1999-12-31	$469.10M	4.31%
1998-12-31	$449.70M	-0.62%
1997-12-31	$452.50M	-1.37%
1996-12-31	$458.80M	11.12%
1995-12-31	$412.90M	13.09%
1994-12-31	$365.10M	4.70%
1993-12-31	$348.70M	-

West Pharmaceutical Services generated $3.07B in revenue during NA 2025, up 6.26% compared to the previous quarter, and up 143.18% compared to the same period a year ago.

West Pharmaceutical Services Revenue by Quarter

Date	Revenue	Change
2025-09-30	$804.70M	5.02%
2025-06-30	$766.20M	9.74%
2025-03-31	$698.20M	-6.72%
2024-12-31	$748.50M	0.21%
2024-09-30	$746.90M	6.40%
2024-06-30	$702.00M	0.96%
2024-03-31	$695.30M	-5.03%
2023-12-31	$732.10M	-2.06%
2023-09-30	$747.50M	-0.89%
2023-06-30	$754.20M	5.35%
2023-03-31	$715.90M	1.06%
2022-12-31	$708.40M	3.21%
2022-09-30	$686.40M	-11.04%
2022-06-30	$771.60M	7.21%
2022-03-31	$719.70M	-1.28%
2021-12-31	$729.00M	3.17%
2021-09-30	$706.60M	-2.42%
2021-06-30	$724.10M	7.91%
2021-03-31	$671.00M	15.63%
2020-12-31	$580.30M	5.84%
2020-09-30	$548.30M	4.06%
2020-06-30	$526.90M	7.25%
2020-03-31	$491.30M	3.41%
2019-12-31	$475.10M	4.23%
2019-09-30	$455.80M	-2.90%
2019-06-30	$469.40M	5.89%
2019-03-31	$443.30M	4.97%
2018-12-31	$422.30M	-2.18%
2018-09-30	$431.70M	-3.60%
2018-06-30	$447.80M	7.72%
2018-03-31	$415.70M	0.02%
2017-12-31	$415.60M	4.37%
2017-09-30	$398.20M	0.15%
2017-06-30	$397.60M	2.55%
2017-03-31	$387.70M	1.41%
2016-12-31	$382.30M	1.49%
2016-09-30	$376.70M	-2.91%
2016-06-30	$388.00M	7.15%
2016-03-31	$362.10M	0.67%
2015-12-31	$359.70M	4.41%
2015-09-30	$344.50M	-4.23%
2015-06-30	$359.70M	7.09%
2015-03-31	$335.90M	-3.97%
2014-12-31	$349.80M	-1.71%
2014-09-30	$355.90M	-3.52%
2014-06-30	$368.90M	6.37%
2014-03-31	$346.80M	1.20%
2013-12-31	$342.70M	0.26%
2013-09-30	$341.80M	-0.78%
2013-06-30	$344.50M	1.50%
2013-03-31	$339.40M	5.57%
2012-12-31	$321.50M	5.83%
2012-09-30	$303.80M	-6.47%
2012-06-30	$324.80M	2.69%
2012-03-31	$316.30M	7.08%
2011-12-31	$295.40M	0.61%
2011-09-30	$293.60M	-4.64%
2011-06-30	$307.90M	4.23%
2011-03-31	$295.40M	6.72%
2010-12-31	$276.80M	1.99%
2010-09-30	$271.40M	-3.69%
2010-06-30	$281.80M	2.58%
2010-03-31	$274.70M	-6.37%
2009-12-31	$293.40M	13.33%
2009-09-30	$258.90M	-0.80%
2009-06-30	$261.00M	7.67%
2009-03-31	$242.40M	-0.98%
2008-12-31	$244.80M	-4.45%
2008-09-30	$256.20M	-8.27%
2008-06-30	$279.30M	3.18%
2008-03-31	$270.70M	5.70%
2007-12-31	$256.10M	-

West Pharmaceutical Services generated $804.70M in revenue during Q3 2025, up 5.02% compared to the previous quarter, and up 114.63% compared to the same period a year ago.

West Pharmaceutical Services Revenue Breakdown

West Pharmaceutical Services Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Proprietary Products	$2.49B	$2.33B	$2.40B	$2.41B	$2.32B
Contract Manufactured Products	$582.00M	$558.70M	$552.50M	$480.40M	$514.70M

West Pharmaceutical Services's latest annual revenue breakdown by segment (product or service), as of Dec 25: Proprietary Products (81.07%), and Contract Manufactured Products (18.93%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20
Contract Manufactured Products	$143.20M	$157.10M	$146.70M	$135.00M	$134.90M	$145.50M	$142.40M	$135.90M	$419.00M	$133.50M	$118.70M	$127.10M	-	-	-	-	-	-	-	-
Proprietary Products	$661.80M	$647.50M	$619.80M	$1.81B	$583.10M	$601.30M	$543.70M	-	-	-	-	-	-	-	-	-	-	-	-	-
Delivery Systems	-	-	-	-	-	-	-	-	-	$144.90M	$135.80M	$120.00M	$117.80M	$129.70M	$136.40M	$126.60M	$127.80M	-	-	-
Packaging Systems	-	-	-	-	-	-	-	-	-	$602.50M	$567.00M	$653.70M	$577.00M	$587.30M	$421.50M	$399.50M	-	-	-	-

West Pharmaceutical Services's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Proprietary Products (82.21%), and Contract Manufactured Products (17.79%).

West Pharmaceutical Services Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
FRANCE	$226.60M	$242.20M	$282.90M	$237.90M	$213.00M
IRELAND	$333.30M	$323.20M	$285.70M	$240.30M	$247.60M
UNITED STATES	$1.33B	$1.23B	$1.24B	$1.29B	$1.20B
Other Europe Countries	$451.00M	$385.50M	$388.10M	$359.20M	$341.30M
Other Countries	$353.30M	$339.00M	$348.50M	$364.30M	$357.40M
GERMANY	$380.30M	$372.50M	$406.10M	$398.70M	$474.30M

West Pharmaceutical Services's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (43.25%), Other Europe Countries (14.67%), GERMANY (12.37%), Other Countries (11.49%), IRELAND (10.84%), and FRANCE (7.37%).

West Pharmaceutical Services Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
LH	Labcorp	$13.95B	$3.56B
DGX	Quest Diagnostics	$11.04B	$2.82B
ZBH	Zimmer Biomet	$8.23B	$2.00B
STE	STERIS	$5.46B	$1.50B
INCY	Incyte	$5.14B	$1.37B
ILMN	Illumina	$4.34B	$1.08B
HOLX	Hologic	$4.10B	-
COO	Cooper Companies	$4.09B	$1.02B
WAT	Waters	$3.17B	$799.89M
WST	West Pharmaceutical Services	$3.07B	$804.70M
MEDP	Medpace	$2.53B	$659.90M

WST Revenue FAQ

What is West Pharmaceutical Services’s yearly revenue?

West Pharmaceutical Services's yearly revenue for 2025 was $3.07B, representing an increase of 6.26% compared to 2024. The company's yearly revenue for 2024 was $2.89B, representing a decrease of -1.98% compared to 2023. WST's yearly revenue for 2023 was $2.95B, representing an increase of 2.27% compared to 2022.

What is West Pharmaceutical Services’s quarterly revenue?

West Pharmaceutical Services's quarterly revenue for Q3 2025 was $804.7M, a 5.02% increase from the previous quarter (Q2 2025), and a 7.74% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $766.2M, a 9.74% increase from the previous quarter (Q1 2025), and a 9.15% increase year-over-year (Q2 2024). WST's quarterly revenue for Q1 2025 was $698.2M, a -6.72% decrease from the previous quarter (Q4 2024), and a 0.42% increase year-over-year (Q1 2024).

What is West Pharmaceutical Services’s revenue growth rate?

West Pharmaceutical Services's revenue growth rate for the last 3 years (2023-2025) was 4.15%, and for the last 5 years (2021-2025) was 8.58%.

What are West Pharmaceutical Services’s revenue streams?

West Pharmaceutical Services's revenue streams in c 25 are Proprietary Products, and Contract Manufactured Products. Proprietary Products generated $2.49B in revenue, accounting 81.07% of the company's total revenue, up 6.75% year-over-year. Contract Manufactured Products generated $582M in revenue, accounting 18.93% of the company's total revenue, up 4.17% year-over-year.

What is West Pharmaceutical Services’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of West Pharmaceutical Services was Proprietary Products. This segment made a revenue of $2.49B, representing 81.07% of the company's total revenue.